Latest filing published 20 Oct 2026 for Arcutis Biotherapeutics, Inc., €1.8M.
Insider track record
No signal scores available.
Larry Todd Edwards: trading record in brief
Larry Todd Edwards discloses dealings in Arcutis Biotherapeutics, Inc. to SEC (Form 4). Over a trading history stretching from 16 September 2026 to 20 October 2026, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 20 October 2026 came the latest disclosure, a transaction for €1.8M in Arcutis Biotherapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Larry Todd Edwards
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 60,376 shares@ US$33.00CommonSEC144:0001628280-26-066520
- 341,980 shares@ US$25.000.23% mcap100.0% of flowCommonSEC144:0001628280-26-062242
2 of 2 declarations
